Improving HIV prevention and care for transgender and gender diverse youth
Official title: RP4 LEAP
Funded at Florida State University · NIH-10993606 · Data updated 2026-11-12
This study is working to help transgender and gender diverse young people, especially those from Black and Latinx communities, by providing support and resources to make it easier for them to get tested for HIV and access prevention and treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Florida State University NIH-funded |
| Lab location | 1 site (Tallahassee, United States) |
| Project start | January 25, 2023 |
| Project end | November 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $1,080,467 |
| NIH project number | 5UM2HD111102-03 |
| Project ID | NIH-10993606 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are transgender and gender diverse youth, particularly those from Black and Latinx backgrounds, who are at risk for or living with HIV.
✕Less likely to help
Patients who do not identify as transgender or gender diverse, or those who are not within the targeted age group may not receive benefits from this research.
What this research studies
This research focuses on addressing the high rates of HIV diagnoses among transgender and gender diverse (TGD) youth, particularly those from Black and Latinx communities. It aims to implement the LEAP intervention, which provides tailored support to tackle social determinants of health that contribute to inequities in HIV prevention and treatment. The approach includes promoting regular HIV testing, increasing access to pre-exposure prophylaxis (PrEP), and ensuring effective antiretroviral therapy (ART) for those living with HIV. By leveraging a multidisciplinary team and diverse geographic locations, the project seeks to create a supportive environment that enhances health outcomes for TGD youth.
Why it matters
Potential benefit: If successful, this research could significantly reduce HIV transmission rates and improve health outcomes for TGD youth of color.
How similar studies have gone: Previous research has shown success in using tailored interventions to improve health outcomes in marginalized populations, indicating a promising approach for this project.
Where this research is happening
-
Florida State University
Tallahassee, United States Active
Researchers
- Principal investigator: Hightow-Weidman, Lisa B — Florida State University
- Study coordinator: Hightow-Weidman, Lisa B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.